| INTRODUC TI ON
Polymyalgia rheumatica (PMR) is a systemic inflammatory disease, typically found in people over 50 years of age, affecting the shoulder and pelvic girdles. [1] [2] [3] Typical symptoms include inflammatory pain and stiffness of the involved joints with elevated inflammatory markers, such as the erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). There is no specific serological marker or test for PMR, and the diagnosis depends on clinical characteristics. Several classification criteria, including clinical characteristics and imaging tests, have been used. 4 Ultrasonography is used to identify bursitis or tenosynovitis in affected lesions, and magnetic resonance imaging and positron emission tomography scans with 18F-fluorodeoxyglucose have been investigated as imaging tools to assess inflammation around large joints in PMR. [5] [6] [7] Studies have shown that levels of circulating proinflammatory cytokines, such as interleukin (IL)-6 and fibrinogen, are increased in active PMR, and their levels represent disease activity. [8] [9] [10] [11] In addition, levels of several other proinflammatory cytokines, including IL-1α, IL-1β, IL-8, and monocyte chemoattractant protein-1, are elevated in symptomatic muscles. 12 Systemic glucocorticoids are the treatment of choice to relieve disease manifestations. 13 Although PMR is generally considered a benign disorder with no adverse effects on long-term survival, most patients with PMR require long-term glucocorticoid therapy, which has several side effects, such as osteoporotic fractures and infection.
Moreover, 20%-55% of patients have relapses in the first year, requiring an increased dose of glucocorticoids. 14 
Immunosuppressant
agents including methotrexate (MTX) are added to taper glucocorticoids and prevent relapse. 15 Clinical characteristics such as female sex, peripheral arthritis, and high ESR or CRP levels are considered risk factors for relapse or prolonged glucocorticoid use. 16 However, there are few specific markers that predict the disease prognosis.
The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are calculated from the complete blood count (CBC) and are known to represent systemic inflammation. 17, 18 The NLR, PLR, and MLR have been studied in infectious or malignant diseases and have been shown to be useful markers for systemic rheumatic diseases such as rheumatoid arthritis (RA) and systemic lupus erythematosus. [19] [20] [21] [22] Recent studies have shown that the NLR and PLR are higher in patients with RA than in healthy controls and associated with disease activity in such patients. 18, 23 However, they have never been investigated in patients with PMR. Therefore, we examined the clinical significance of NLR, PLR, and MLR in Korean patients with PMR. The NLR, PLR, and MLR in patients with PMR were compared with those of patients with RA.
In addition, their correlations with disease activity markers, clinical features, and disease course were evaluated.
| ME THODS

| Subjects
A total of 94 patients with PMR and 242 patients with RA aged 50 years or older who had been initially diagnosed at the rheumatology clinic of university-based tertiary hospitals were enrolled between January 2008 and June 2018. The diagnosis of PMR was based on Bird's criteria, and a diagnosis of probable PMR was made if more than three of seven criteria were met. 24 Patients were excluded if they had other rheumatic diseases, including systemic lupus erythematosus, systemic infections, or malignancy. The diagnosis of RA was based on the American College of Rheumatology 1987 revised criteria. 25 
| Statistical analysis
The chi-square test was used to compare categorical variables for the clinical characteristics between patients with PMR and RA. The independent t test was used to compare the NLR, PLR, and MLR levels according to disease manifestations, and the clinical characteristics of patients with active and inactive PMR. Performing the Shapiro-Wilk test on all three ratios gave P-values < .0001, which does not indicate a normal distribution. However, each group was sufficiently large to apply the t test or chi-square test. Spearman's correlation was used to assess the correlations between disease activity markers and NLR, PLR, or MLR. The correlation coefficient, r, shows the statistical strength of the relationship between two variables. IBM SPSS 23.0 (SPSS) was used for the statistical analyses.
| RE SULTS
| Clinical characteristics of patients with PMR and RA
The study enrolled 94 patients with PMR and 242 patients with RA.
The mean age at disease onset differed with the diseases and was 64.7 ± 9.7 and 61.4 ± 8.7 years (P = .003), respectively (Table 1) . No patients with PMR and 129 (76%) patients with RA had anti-CCP antibody. Symptom duration before presenting to the hospital was shorter in patients with PMR than in patients with RA (5.4 ± 5.8 vs 9.0 ± 10.7 months, P = .002). The number of tender and swollen joints was lower, and the visual analogue scale (VAS) score was higher in patients with PMR than in those with RA (all P < .001). In terms of the laboratory results, hemoglobin count was lower and the white blood cell (WBC) and platelet counts were higher in patients with PMR than in those with RA (all P < .001). Neutrophil count was higher, and lymphocyte count was lower in patients with PMR than in those with RA (all P < .001). ESR and CRP levels were higher in patients with PMR than in those with RA (all P < .001). Uric acid and albumin levels were lower in patients with PMR than in those with RA (P = .034 and P < .001). Table 2 shows the levels of NLR, PLR, and MLR in patients with PMR and RA. When they were matched by age and gender, NLR TA B L E 1 Patient clinical characteristics of patients with platelet-lymphocyte ratio (PLR) and rheumatoid arthritis (RA) (P = .003, Figure 1C ). When they were matched by ESR and CRP, NLR, PLR, and MLR did not differ between the patients with PMR and RA.
| NLR, PLR, and MLR of patients with PMR and RA
| Association between NLR, PLR, and MLR and disease activity markers in PMR
Neutrophil-to-lymphocyte ratio level was correlated with WBC TA B L E 2 Comparison of neutrophillymphocyte ratio, platelet-lymphocyte ratio, and monocyte-lymphocyte ratio between patients with polymyalgia rheumatic (PMR) and rheumatoid arthritis (RA) F I G U R E 1 Neutrophil-to-lymphocyte ratio (NLR) (A), platelet-to-lymphocyte ratio (PLR) (B), and monocyte-to-lymphocyte ratio (MLR) (C) in 94 patients with polymyalgia rheumatica (PMR) and 94 patients with rheumatoid arthritis (RA) matched by age and sex. Data were expressed as the mean ± SD. An independent t test was used for statistical analysis 
| Changes in NLR, PLR, and MLR according to disease activity in PMR
| Clinical characteristics including the levels of NLR, PLR, and MLR according to prognosis in PMR patients
We evaluated differences in NLR, PLR, and MLR levels between the remission group who had no relapse and chronic course group with relapse manifestations. However, the clinical manifestations, including NLR, PLR, and MLR, did not differ between the two groups (data not shown). Patients with a chronic course of PMR had higher counts of swollen joints (2.26 ± 4.97 vs 0.97 ± 2.73, P = .03) and more frequent flares (2.07 ± 1.63 vs 0.41 ± 0.6, P < .001) compared with those with remission. However, NLR, PLR, and MLR did not differ between the remission and chronic course groups in patients with PMR.
| D ISCUSS I ON
Although patients with PMR had fewer tender or swollen joints than patients with RA, pain scores and levels of acute-phase reactants were higher in patients with PMR. These differences are derived from different characteristics of the two diseases; RA is involved in various peripheral joints, whereas PMR involves a small number of large joints and elevated inflammatory levels are essential for diagnosis. Patients with PMR had higher NLR, PLR, and MLR than patients with RA when they were matched by sex and age, but NLR, PLR, and MLR were not different between the groups when they were matched by CRP and ESR levels. CRP is known to be more specific and sensitive than ESR in assessing PMR disease activity. 3, 26 As high levels of CRP are indicative of an inflammatory response involving infectious or non-infectious disorders, increased NLR, PLR, and MLR levels also show an activated inflammatory state in patients with PMR. Moreover, changes in CRP were correlated with changes in NLR, PLR, and MLR in follow-up data of patients with PMR. Combined values of NLR or PLR and CRP have been studied as a more reliable marker to predict prognosis or evaluate the severity of malignant or infectious diseases. 27, 28 Constitutional symptoms including fever, weight loss, and headache occur in 40%-50% of patients with PMR, and fever is known to be a characteristic symptom of isolated PMR. 3 relationship between platelets and headache. 29 Patients with migraine, a primary form of headache, had higher platelet counts and lower platelet membrane fluidity or activity compared with controls. 30, 31 Platelet-leukocyte interaction releases inflammatory mediators, including interleukins, and platelet serotonin and nitric oxide are known to be secreted and cause headache symptoms. 32, 33 Whether a patient with PMR reaches remission or continues with chronic progression is important in establishing treatment plans or This study had several limitations due to the research method and the study population. There was no biopsy-proven giant cell arteritis (GCA), and GCA could not be analyzed. While GCA is a major comorbidity in patients with PMR, it is 20 times less common in Asian populations compared with Caucasian patients. 34, 35 This study represents only the characteristics of Asian patients with PMR. In addition, we reviewed the clinical data retrospectively, so the data from some patients were missing. Furthermore, there may have been selection bias since the data were obtained from a single center. In conclusion, patients with PMR had higher NLR, PLR, and MLR than patients with RA. NLR, PLR, and MLR levels were associated with CRP and albumin in patients with PMR. Fever in patients with PMR was associated with elevated NLR and MLR, and headache was associated with elevated PLR. After disease activity improved, NLR, MLR, and PLR levels decreased. Therefore, NLR and PLR levels at diagnosis are associated with disease activity in patients with PMR. 
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